The Personalised Medicine Concept represents a groundbreaking advancement in personalised nutrition and medicine...
Data from over 1 million Tablo treatments among the findings presented at the American Society of Nephrology’s Kidney Week 2025...
This transition will contribute to enhanced and faster diagnostics, ultimately improving the care they provide for their patients...
The Company's next-generation diagnostics technology, enhanced by proprietary AI models, enables real-time PCR diagnostics at the point-of-care...
AIxMed's AIxURO solution is specifically developed to assist in the analysis of non-invasive urine cytology specimens...
The successful filing of the XJ LLM represents a milestone in Fangzhou’s AI-enabled chronic disease management ecosystem...
Dosimetry portfolio strengthened with Medical Imaging QA and AI validation ...
The new findings show that patients can safely have additional arteries treated immediately during the first procedure to treat the acute event...
The 52-week data from these two Phase III clinical trials demonstrate the durability of response and highlight the comprehensive long-term clinical benefits of HTD1801 in patients with T2DM...
Renowned pain management and medical technology leader to accelerate Glucotrack’s strategy for integrated glucose monitoring applications, building on the Company’s 2024 expansion into epidural monitoring ...
